Get started
Author

C. Hu

NRG LU008: Phase III Prospective Randomized Trial of Primary Lung Tumor Stereotactic Body Radiation Therapy (SBRT) Followed by Concurrent Mediastinal Chemoradiation for Locally-Advanced Non-Small Cell Lung Cancer (LA-NSCLC)
2024 · C.B. Simone, C. Hu, et al. · International Journal of Radiation Oncology*Biology*Physics · 12
EP02.04-007 Phase 2 Trial of Neoadjuvant KRASG12C Directed Therapy with Adagrasib (MRTX849) With or Without Nivolumab in Resectable NSCLC (Neo-KAN)
2022 · S.C. Scott, C. Hu, et al. · Journal of Thoracic Oncology · 10
PDF
SWOG/NRG S1914: A Randomized Phase III Trial of Induction/Consolidation Atezolizumab + SBRT vs. SBRT Alone in High Risk, Early-Stage NSCLC (NCT#04214262)
2022 · M.E. Daly, M. Redman, et al. · International Journal of Radiation Oncology*Biology*Physics · 9
Comprehensive Patient Reported Outcomes (PROs) from NRG LU005: A Randomized Trial Of Chemoradiation (CRT) ± Atezolizumab In Limited-Stage Small Cell Lung Cancer (LS-SCLC)
2025 · B. Movsas, C. Hu, et al. · International Journal of Radiation Oncology*Biology*Physics · 1
Stage IIIA Non‐Small Cell Lung Cancer Treatment and Outcomes: A Single Institution Retrospective Analysis
2025 · Richard Duan, Michelle Kwan, et al. · Thoracic Cancer · 1
PDF
OA12.03 Neoadjuvant Nivolumab or Nivolumab Plus Ipilimumab in Resectable Diffuse Pleural Mesothelioma
2025 · J. Reuss, R.J. Mehran, et al. · Journal of Thoracic Oncology
EP.13.37 Immunotherapy Plus Chemoradiotherapy for Limited-Stage Small Cell Lung Cancer: A Systematic Review and Meta-Analysis of Randomized Trials
2025 · C.C. Lee, C.K. Lee, et al. · Journal of Thoracic Oncology
EP14.03-005 Role of Radiotherapy Fraction in Limited-Stage SCLC: a Meta-Analysis of 8585 Reconstructed Individual Patient Data
2022 · J. Zhao, L. Wang, et al. · Journal of Thoracic Oncology
Works count: 8
Citation count: 33
H-index: 3
I10-index: 2
Year
Topic
Type